atai Life Sciences Company Kures Therapeutics Appoints Dr. Chad Beyer as Chief Executive Officer

Articles | June 30, 2022

June 30, 2022 Dr. Chad Beyer will join as CEO on July 1, 2022   NEW YORK, June 30, 2022 (GLOBE NEWSWIRE) — Kures Therapeutics, Inc (“Kures”), an atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”) company focused on developing treatment options to better manage addictions, depression, and pain, today announced… Read More

Stephen Bardin to Join atai Life Sciences as CFO Designate

News | June 17, 2022

Stephen Bardin to Join atai Life Sciences as CFO Designate June 17, 2022 Stephen Bardin will join as CFO Designate on June 27, 2022 After a transition period, atai’s current CFO Greg Weaver will be moving into a part time strategic advisory role NEW YORK and BERLIN, June… Read More